{"id":"W2522960478","doi":"10.1016/s0168-8278(16)01707-4","title":"RETRACTED: PS 124 - Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease","year":2016,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":true,"has_abstract":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Vedolizumab; Primary sclerosing cholangitis; Inflammatory bowel disease; Medicine; Dosing; Gastroenterology; Ulcerative colitis; Internal medicine; Inflammation; Disease; Biliary disease; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Concerns/Issues about Data;Unreliable Results and/or Conclusions;","date":"12/15/2016 0:00","openalex_flagged":true},"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003106837,0.000484349,0.0008279494,0.0004208272,0.0006024896,0.001397387,0.001174039,0.002985297,0.009115136],"category_scores_gemma":[0.01155837,0.0002277044,0.0009710602,0.0003681714,0.0005592529,0.0008565729,0.0004447357,0.003779604,0.004508369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001940753,"about_ca_system_score_gemma":0.001962706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002306907,"about_ca_topic_score_gemma":0.003540016,"domain_scores_codex":[0.9986596,0.0003027765,0.0002709473,0.00009820877,0.000514046,0.0001543955],"domain_scores_gemma":[0.9930494,0.002708667,0.000598762,0.0005094414,0.002260713,0.0008730499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01136112,0.000504323,0.004261353,0.0005520105,0.0002965893,0.001546052,0.00009460381,0.0005197437,0.002812016,0.001021512,0.6921826,0.284848],"study_design_scores_gemma":[0.006828689,0.005720299,0.03570546,0.0005178277,0.0005534035,0.002163165,0.0001335776,0.002892072,0.008532545,0.002009668,0.9348612,0.00008198761],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1181241,0.0231758,0.006157625,0.5337804,0.2390395,0.001574797,0.01235335,0.00341637,0.06237812],"genre_scores_gemma":[0.4482618,0.01097398,0.008989083,0.296121,0.08946986,0.0009504586,0.007351555,0.0005856583,0.1372965],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9970147,"threshold_uncertainty_score":0.03049314,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01566401422750434,"score_gpt":0.2536198861155816,"score_spread":0.2379558718880773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}